BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 12947372)

  • 1. Impact of age on procedural and 1-year outcome in percutaneous transluminal coronary angioplasty: a report from the NHLBI Dynamic Registry.
    Cohen HA; Williams DO; Holmes DR; Selzer F; Kip KE; Johnston JM; Holubkov R; Kelsey SF; Detre KM;
    Am Heart J; 2003 Sep; 146(3):513-9. PubMed ID: 12947372
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of outcomes of percutaneous coronary interventions in patients of three age groups (<60, 60 to 80, and >80 years) (from the New York State Angioplasty Registry).
    Feldman DN; Gade CL; Slotwiner AJ; Parikh M; Bergman G; Wong SC; Minutello RM;
    Am J Cardiol; 2006 Nov; 98(10):1334-9. PubMed ID: 17134624
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The dilemma of success: percutaneous coronary interventions in patients > or = 75 years of age-successful but associated with higher vascular complications and cardiac mortality.
    Assali AR; Moustapha A; Sdringola S; Salloum J; Awadalla H; Saikia S; Ghani M; Hale S; Schroth G; Rosales O; Anderson HV; Smalling RW
    Catheter Cardiovasc Interv; 2003 Jun; 59(2):195-9. PubMed ID: 12772238
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Percutaneous coronary interventions in elderly patients: clinical indications and adjunctive medical treatment. The Italian Drug Evaluation in Angioplasty (IDEA) study].
    Bossi I; Piccaluga E; Scatturin M; Corvaja N; Pasquetto G; Steffanon L; Oberhollenzer R; Colombo P; Bolognese L; Savonitto S
    G Ital Cardiol (Rome); 2006 Feb; 7(2):136-44. PubMed ID: 16532725
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The impact of ejection fraction on outcomes after percutaneous coronary intervention in patients with congestive heart failure: an analysis of the National Heart, Lung, and Blood Institute Percutaneous Transluminal Coronary Angioplasty Registry and Dynamic Registry.
    Holper EM; Blair J; Selzer F; Detre KM; Jacobs AK; Williams DO; Vlachos H; Wilensky RL; Coady P; Faxon DP;
    Am Heart J; 2006 Jan; 151(1):69-75. PubMed ID: 16368294
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug-eluting stents in the elderly: long-term (> one year) clinical outcomes of octogenarians in the DESIRE (Drug-Eluting Stents In the REal world) registry.
    Costa JR; Sousa A; Moreira AC; Costa RA; Maldonado G; Cano MN; Egito ET; Romano ER; Barbosa M; Pavanello R; Jardim C; Cury A; Berwanger O; Sousa JE
    J Invasive Cardiol; 2008 Aug; 20(8):404-10. PubMed ID: 18688065
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interactions between heparins, glycoprotein IIb/IIIa antagonists, and coronary intervention. The Global Registry of Acute Coronary Events (GRACE).
    Brieger D; Van de Werf F; Avezum A; Montalescot G; Kennelly BM; Granger CB; Goodman SG; Dabbous OH; Agnelli G;
    Am Heart J; 2007 Jun; 153(6):960-9. PubMed ID: 17540196
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The impact of age on outcomes after coronary artery bypass surgery versus stent-assisted percutaneous coronary intervention: one-year results from the Stent or Surgery (SoS) trial.
    Zhang Z; Mahoney EM; Spertus JA; Booth J; Nugara F; Kolm P; Stables RH; Weintraub WS
    Am Heart J; 2006 Dec; 152(6):1153-60. PubMed ID: 17161069
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Percutaneous coronary revascularization in patients over eighty: acute and long-term results].
    Lettieri C; Buffoli F; Romano M; Aroldi M; Baccaglioni N; Tomasi L; Rosiello R; Agostini F; Kuwornu H; Pepi P; Izzo A; Zanini R
    Ital Heart J Suppl; 2005 Sep; 6(9):588-98. PubMed ID: 16281718
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gender-based outcomes in percutaneous coronary intervention with drug-eluting stents (from the National Heart, Lung, and Blood Institute Dynamic Registry).
    Abbott JD; Vlachos HA; Selzer F; Sharaf BL; Holper E; Glaser R; Jacobs AK; Williams DO;
    Am J Cardiol; 2007 Mar; 99(5):626-31. PubMed ID: 17317361
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcomes after percutaneous coronary intervention of ostial lesions in the era of drug-eluting stents.
    Freeman M; Clark DJ; Andrianopoulos N; Duffy SJ; Lim HS; Brennan A; Charter K; Shaw J; Horrigan M; Ajani AE; Sebastian M; Reid CM; Farouque HM;
    Catheter Cardiovasc Interv; 2009 May; 73(6):763-8. PubMed ID: 19309731
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Prognosis after acute coronary syndrome. Lack of difference according to the sex].
    Bounhoure JP; Farah B; Fajadet J; Marco J
    Bull Acad Natl Med; 2004; 188(3):383-97; discussion 397-9. PubMed ID: 15584651
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical outcomes following percutaneous coronary intervention with drug-eluting vs. bare-metal stents in dialysis patients.
    Halkin A; Selzer F; Marroquin O; Laskey W; Detre K; Cohen H
    J Invasive Cardiol; 2006 Dec; 18(12):577-83. PubMed ID: 17197706
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Usefulness of noncoronary vascular disease in predicting adverse events in the year following percutaneous coronary intervention.
    Naidu SS; Vlachos H; Faxon D; Jacobs AK; Selzer F; Detre K; Wilensky RL
    Am J Cardiol; 2005 Mar; 95(5):575-80. PubMed ID: 15721094
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Should patients in cardiogenic shock undergo rescue angioplasty after failed fibrinolysis: comparison of primary versus rescue angioplasty in cardiogenic shock patients.
    Kunadian B; Vijayalakshmi K; Dunning J; Thornley AR; Sutton AG; Muir DF; Wright RA; Hall JA; de Belder MA
    J Invasive Cardiol; 2007 May; 19(5):217-23. PubMed ID: 17476036
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Marked improvements in outcomes of contemporary percutaneous coronary intervention in patients with diabetes mellitus.
    Freeman AM; Abbott JD; Jacobs AK; Vlachos HA; Selzer F; Laskey WK; Detre KM; Williams DO
    J Interv Cardiol; 2006 Dec; 19(6):475-82. PubMed ID: 17107360
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Primary angioplasty in patients > or = 75 years old with ST-elevation myocardial infarction - one-year follow-up results.
    Ciszewski A; Karcz M; Kepka C; Bekta P; Ksiezycka E; Przyłuski J; Debski A; Witkowski A; Ruzyłło W
    Kardiol Pol; 2008 Aug; 66(8):828-33; discussion 834-6. PubMed ID: 18803134
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical characteristics and early mortality of patients undergoing coronary artery bypass grafting compared to percutaneous coronary intervention: insights from the Australasian Society of Cardiac and Thoracic Surgeons (ASCTS) and the Melbourne Interventional Group (MIG) Registries.
    Yan BP; Clark DJ; Buxton B; Ajani AE; Smith JA; Duffy SJ; Shardey GC; Skillington PD; Farouque O; Yii M; Yap CH; Andrianopoulos N; Brennan A; Dinh D; Reid CM; ;
    Heart Lung Circ; 2009 Jun; 18(3):184-90. PubMed ID: 19268632
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Revascularization use and survival outcomes after cardiac catheterization in British Columbia and Alberta.
    Thompson CR; Humphries KH; Gao M; Galbraith PD; Norris C; Carere RG; Knudtson ML; Ghali WA;
    Can J Cardiol; 2004 Dec; 20(14):1417-23. PubMed ID: 15614334
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety and benefit of early elective percutaneous coronary intervention after successful thrombolytic therapy for acute myocardial infarction.
    Sim DS; Jeong MH; Ahn Y; Kim YJ; Chae SC; Hong TJ; Seong IW; Chae JK; Kim CJ; Cho MC; Seung KB; Park SJ;
    Am J Cardiol; 2009 May; 103(10):1333-8. PubMed ID: 19427424
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.